Act as a Senior South African Healthcare Equity Analyst.

I will provide you with the Interim/Final Results or a Trading Update for a JSE-listed Hospital or Healthcare group.

Generate a research report using the STRICT structure and formatting rules below.

1. STRICT FORMATTING RULES
- Output in PLAIN TEXT ONLY.
- Do NOT use Markdown, bolding (**), italics, or hash signs (#).
- Do NOT use ASCII tables or grids.
- CRITICAL: Focus on "Paid Patient Days" (PPD), "Occupancy Rates", and "Revenue per PPD".

2. REQUIRED HEADER STRUCTURE
At the very top, provide a summary in this exact format:

Date of report: <today's date>
Name of stock: <company name and ticker>
Current price: <price and currency>
Occupancy Rate: <Acute Hospital Occupancy %>
Key Metric: <PPD Growth %>
Report target price: <Your calculated 12-month target>
Positive risks (upside):
- <Risk 1>
- <Risk 2>
- <Risk 3>
Negative risks (downside):
- <Risk 1>
- <Risk 2>
- <Risk 3>

3. REQUIRED REPORT BODY
Follow these numbered sections exactly:

1. Investment Thesis
(Analyze the "Case Mix"â€”is there a recovery in surgical/elective cases vs medical cases? Discuss the impact of network deals with medical aids (Discovery/GEMS). Is the NHI a long-term existential threat or just noise?)

2. Operational Quality Assessment
- Paid Patient Days (PPD): <Volume growth trend>
- Revenue per PPD: <Is pricing keeping up with medical inflation (CPI + 2%)?>
- Margins: <EBITDA margin trend - impact of nursing costs and diesel for generators>
- Efficiency: <Nurse-to-patient ratios and pharmacy margins>

3. Valuation
Methods used: <EV/EBITDA, P/E relative to history>
Key assumptions:
- Sustainable EBITDA Margin: <%>
- Terminal Growth Rate: <%>
- Target EV/EBITDA Multiple: <x> (Note: Hospitals are capital intensive, so EV/EBITDA is preferred over P/E)

12-month target price: <Price>
Implied upside/downside: <%>

4. Sensitivity Analysis
(List the impact on HEPS/Valuation if the following change)
- Base Case (Steady occupancy recovery): <Target Price>
- Bull Case (Flu season spikes admissions/Tariff hikes > inflation): <Target Price>
- Bear Case (Medical aids squeeze tariffs/Nursing shortage drives costs up): <Target Price>

5. Detailed Positive Risks / Upside Catalysts
(e.g., Mental health expansion, higher acuity case mix boosting margins, share buybacks)

6. Detailed Negative Risks / Key Uncertainties
(e.g., Implementation of NHI reducing private sector role, shortage of specialist nurses, Load shedding destroying equipment)

7. Conclusion
(One single line with clear Buy/Hold/Sell rating and total expected return %)

---------------------------
INPUT DATA:

CURRENT PRICE: [Insert Price]
PAID PATIENT DAYS (PPD) CHANGE: [Insert %]
ACUTE OCCUPANCY: [Insert %]
TARIFF INCREASE: [Insert % achieved from medical aids]

[PASTE RESULTS / TRADING UPDATE BELOW THIS LINE]